It also depends on what comes in to the shell. Aptayl has spoken...

It also depends on what comes in to the shell. Aptayl has spoken to the corporate advisor, who reckons TDX will probably remain in the bio-sciences, so resources may not happen. Also, it depends on the quality or risk of the company backed in. There have been two shells who have had companies backed in- can't remember the codes,but on news of the purchases, the companies went back to .001 (one purchased a kind of multi-level marketing company; the other some resource in Zimbabwe, of all places). Imagine how many companies and "assets" there are in the world, who would just love to be bought out: it doesn't mean they are necessarily good ones or wise choices. There are loads of ASX-listed companies where one can see the Directors have bought up something, get no sales of it, and live off Director fees from capital raisings. Not a bad life for them, probably. They can live a long time from ANN's that say they are in "discussions" regarding their products.